Cipla LtdNSE: CIPLA

Press Release Jun 15 2021

· Issued by Cipla Ltd

Filed with NSE ·

Cipla Limited has informed the Exchange regarding a press release dated Jun 14, 2021, titled "Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol ".

View Attachment

6ix hasn’t read this filing yet.

Cipla Ltd on 6ix

Earlier from Cipla

Later from Cipla

All Cipla news releases